Global Health P/E Ratio
Global Health P/E ratio. Global Health (MEDANTA) P/E ratio is 62.8 (High), EPS (TTM) ₹20.71, current price ₹1478.30 on NSE vs historical average P/E of 44.77 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Check MEDANTA market value to track the company's total market size over time.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
MEDANTA P/E Ratio — Valuation Signal & Historical Context
Global Health P/E 62.8 vs historical average 44.77, range 27.32–57.57 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Global Health share price chart.
- Stock appears overvalued with PE of 62.8, suggesting caution for new investments
- Current PE is 40.3% above historical average
- Trading at premium to sector average PE of 52.15
Global Health P/E Ratio Historical Trend
MEDANTA annual price-to-earnings ratio — 4 years, EPS and year-end price. Current P/E 62.8 vs historical average 44.77. Also explore Global Health share price performance to track price trends across different timeframes.
MEDANTA Historical P/E Ratio — EPS, Year-End Price & Valuation
Global Health annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 57.57 | 19.12 | ₹1100.70 | NSE | High |
| 2024 | 50.36 | 18.89 | ₹951.35 | NSE | High |
| 2023 | 27.32 | 16.84 | ₹460.10 | NSE | High |
| 2022 | 43.85 | 9.47 | ₹415.30 | NSE | High |
MEDANTA vs Healthcare Peers — P/E Ratio Comparison
Global Health P/E 62.8 vs Healthcare average 52.15, median 29.4 — range 2.0–733.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |